CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...

Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaThe ...

Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.

Not all zombie skin cells are the same. New research reveals three unique subtypes with different roles in aging and disease, ...

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at ...

Pharming Group N.V. ("Pharming” or "the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following ...